Document is current
Any future updates will be listed below
-
Authors
Boone-Heinonen, Janne
Lyon-Scott, Kristin
Springer, Rachel
Schmidt, Teresa
Vesco, Kimberly K.
Booman, Anna
Dinh, Dang
Fortmann, Stephen P.
Foster, Byron A.
Hauschildt, Jenny
Liu, Shuling
O’Malley, Jean
Palma, Amy
Snowden, Jonathan M.
Stratton, Kalera
Tran, Sarah
-
Funding
Funding for this research was provided by:
National Institutes of Health (1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1, 1R01DK118484-01A1)
- License Information
-
More Information
Article History
Received: 12 May 2023
Accepted: 2 March 2024
First Online: 23 March 2024
Declarations
:
: The PROMISE study was approved by the Institutional Review Board at Oregon Health & Science University (Study 00020810), the lead site for the study. This study involved analysis of existing data and was granted a waiver of informed consent and authorization by the Institutional Review Board at Oregon Health & Science University. All study procedures were carried out in accordance with federal and institutional privacy and security guidelines and regulations.
: Not applicable.
: Dr. Vesco reports that her institution received funding from Pfizer Independent Grants for Learning and Change for an unrelated study. All the other authors declare no competing interest.
